Journey Medical (DERM) Deferred Taxes (2020 - 2021)

Journey Medical (DERM) reported Deferred Taxes of $8.3 million for Q4 2021, up 2281.27% on a YoY basis from $347168.2 in Q4 2020, and up 351.51% quarter-over-quarter from -$3.3 million in Q3 2021.

Journey Medical (DERM) Deferred Taxes (2020 - 2021) Analysis & Trends

Journey Medical has reported Deferred Taxes for 2 years, with the latest figure at $8.3 million in Q4 2021.

  • For the quarter ending Q4 2021, Deferred Taxes rose 2281.27% year-over-year to $8.3 million; the trailing twelve-month figure through Dec 2021 stood at $1.6 million (changed N/A YoY), and the FY2021 full-year result was $1.6 million, up 567.46% from the prior year.
  • Deferred Taxes for Q4 2021 stood at $8.3 million, up from -$3.3 million in the prior quarter.
  • The five-year high for Deferred Taxes was $8.3 million in Q4 2021, with the low at -$3.5 million in Q2 2021.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Deferred Taxes (Qtr)
1 Teva Pharmaceutical Industries 38.34 Bn 34.60 Bn 1.97 Bn -22.00 Mn
2 Zoetis 33.27 Bn 31.33 Bn 1.62 Bn 34.00 Mn
3 United Therapeutics 23.75 Bn 21.60 Bn 648.10 Mn 25.90 Mn
4 Aurora Cannabis 17.11 Bn 17.03 Bn 33.43 Mn 14,341.73
5 Neurocrine Biosciences 16.37 Bn 15.05 Bn 800.70 Mn -61.10 Mn
6 Elanco Animal Health 11.78 Bn 11.35 Bn 785.00 Mn -
7 Alkermes 7.05 Bn 6.54 Bn -116.06 Mn -8.79 Mn
8 Lantheus Holdings 6.49 Bn 5.99 Bn 230.92 Mn 19.33 Mn
9 Hims & Hers Health 6.19 Bn 5.44 Bn 396.79 Mn -13.98 Mn
10 Journey Medical 163.83 Mn 136.61 Mn 9.70 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2021 8.27 Mn
Sep 30, 2021 -3.29 Mn
Jun 30, 2021 -3.48 Mn
Mar 31, 2021 69,000.00
Dec 31, 2020 -379,000.00